🇺🇸 Giredestrant in United States

18 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 18

Most-reported reactions

1. Colitis Ulcerative — 7 reports (38.89%)
2. Hypercalcaemia — 2 reports (11.11%)
3. Urinary Tract Infection — 2 reports (11.11%)
4. Acute Kidney Injury — 1 report (5.56%)
5. Adrenal Insufficiency — 1 report (5.56%)
6. Agitated Depression — 1 report (5.56%)
7. Anaemia — 1 report (5.56%)
8. Anxiety — 1 report (5.56%)
9. Atrial Fibrillation — 1 report (5.56%)
10. Atrial Flutter — 1 report (5.56%)

Source database →

Frequently asked questions

Is Giredestrant approved in United States?

Giredestrant does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Giredestrant in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.